Whitebox Advisors’s ProKidney PROK Stock Holding History

Whitebox Advisors’s Portfolio PROK Stock Details PROK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-250,000	Closed	-$2.48M	–	931
2022 Q1	$2.48M	Hold	250,000	–	–	0.05%	150
2021 Q4	$2.48M	Hold	250,000	–	–	0.05%	146
2021 Q3	$2.45M	Hold	250,000	–	–	0.05%	137
2021 Q2	$2.53M	Buy	+250,000	New	+$2.53M	0.05%	119

Other funds holding PROK

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

ACA

Arena Capital Advisors Los Angeles, California $208M AUM 11.42% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Governors Lane New York $1.56B AUM 30.42% 1-Year Est. Return

Whitebox Advisors's PROK Position: Q2 2022 in Review

Whitebox Advisors sold out of ProKidney (PROK) in Q2 2022, closing a stake of 250,000 shares — an estimated $2.48M sold.

Whitebox Advisors first reported a position in PROK in Q2 2021 and held it in 4 quarters. The position peaked at $2.53M in Q2 2021. 67 funds tracked by Wall St. Rank hold PROK as of Q2 2022.

Whitebox Advisors reported no remaining ProKidney position as of Q2 2022 after selling out during the quarter.
Whitebox Advisors sold 250,000 ProKidney shares in Q2 2022, an estimated $2.48M.
Whitebox Advisors first reported a position in ProKidney in Q2 2021 and held it in 4 quarters.
Whitebox Advisors's ProKidney position peaked at $2.53M in Q2 2021.
67 funds tracked by Wall St. Rank held ProKidney as of Q2 2022.

Based on Whitebox Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.